Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin and Valsartan in Dyslipidemic Hypertensive Patients
NCT00171327Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hypertension (HTN) and dyslipidemia comparing Fluvastatin Start with Valsartan Start (2 arms). Primary endpoints: Percent change from baseline in brachial artery flow-mediated vasodilation at 8 weeks and Percent change from baseline in brachial artery flow-mediated vasodilation after 16 weeks compared to 8 weeks. Started Jul 2004; status: completed.
02
Drugs
fluvastatinvalsartan
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT00171327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171327.